title: Development of novel monoclonal antibodies for the analysis of functional sites in FGF-2.
abstract: Fibroblast growth factor 2 (FGF-2) can function as a potent mitogen, as well as a survival factor for a variety of mammalian cell types. The biological effects of FGF-2 are mediated by its interaction with two types of cellular binding sites: (1) high affinity tyrosine kinase receptors; and (2) low affinity heparan sulfate proteoglycans (HSPGs) on the cell surface. Although numerous FGF-2 antibodies have been used previously to analyze its biological actions, few studies have utilized antibodies to analyze domains within FGF-2 involved in its interactions with the two binding sites. In this report, we describe the generation and use of two monoclonal antibodies against human recombinant FGF-2 (254F1 and 256A12) that inhibit FGF-2 function. However, these antibodies appear to target preferentially different domains within the FGF-2 molecule, and therefore differentially influence the interactions of FGF-2 with its low and high affinity receptors. 254F1 is a more effective inhibitor of the high affinity, receptor tyrosine kinase binding site, whereas 256A12 appears to be a better inhibitor of the low affinity, HSPG interactions. We also demonstrate that the two antibodies are potent inhibitors of FGF-2 stimulated vascular cell proliferation, and as such have potential use in the treatment of vascular hyperproliferative diseases.
authors.affiliation: Department of Pharmacology, Texas Biotechnology Corporation, Houston 77030, USA. arege@tbc.com
authors.forename: A A
authors.initials: AA
authors.lastname: Rege
authors.forename: R J
authors.initials: RJ
authors.lastname: Bjercke
authors.forename: D
authors.initials: D
authors.lastname: Erichsen
authors.forename: R
authors.initials: R
authors.lastname: Owens
authors.forename: C C
authors.initials: CC
authors.lastname: Stephan
authors.forename: T A
authors.initials: TA
authors.lastname: Brock
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D001665:Binding Sites; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000276:immunology; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000276:immunology*; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology; D011994:Recombinant Proteins / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D019812:Heparan Sulfate Proteoglycans; D010455:Peptides; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2